Diaz-Hernandez Juan I, Almeida Angeles, Delgado-Esteban Maria, Fernandez Emilio, Bolaños Juan P
Unidad de Investigación, Hospital Universitario de Salamanca, Spain.
J Biol Chem. 2005 Nov 25;280(47):38992-9001. doi: 10.1074/jbc.M507065200. Epub 2005 Sep 23.
Glutathione deficiency is an early biochemical feature that occurs during apoptotic neuronal death associated with certain neurological disorders such as Parkinson disease. However, whether specific targeting of glutathione biosynthesis in neurons is sufficient to trigger neurodegeneration remains undetermined. To address this issue, we used a vector-based small hairpin RNA (shRNA) strategy to knock down each subunit of glutamate-cysteine ligase (GCL; gamma-glutamylcysteine synthetase), the heterodimeric enzyme that catalyzes the rate-limiting step of glutathione biosynthesis. Independent targeting of the catalytic and modulatory subunits by shRNA caused disruption of GCL as assessed by Northern and Western blotting, enzyme activity, and glutathione concentrations. Silencing each subunit in primary cortical neurons spontaneously elicited time-dependent apoptotic death, an effect that was synergistic with glutamate or nitric oxide treatment. Moreover, neuronal apoptosis by GCL knockdown was rescued by expressing the corresponding subunit full-length cDNA carrying silent mutations within the shRNA target cDNA sequence and by incubating neurons with gamma-glutamylcysteine or glutathione ethyl ester. In contrast, supplying glutathione precursors to neurons from co-cultured astrocytes did not prevent the apoptotic death triggered by GCL knockdown. Finally, overexpressing the catalytic (but not modulatory) GCL subunit full-length cDNA increased enzyme activity and glutathione concentrations, yielding neurons more resistant to glutamate- or nitric oxide-mediated apoptosis. Thus, specific and independent disruption of each subunit of GCL in neurons can be said to cause a primary decrease in glutathione that is sufficient to promote neurodegeneration.
谷胱甘肽缺乏是一种早期生化特征,发生在与某些神经系统疾病(如帕金森病)相关的凋亡性神经元死亡过程中。然而,在神经元中特异性靶向谷胱甘肽生物合成是否足以引发神经退行性变仍未确定。为了解决这个问题,我们使用基于载体的小发夹RNA(shRNA)策略来敲低谷氨酸-半胱氨酸连接酶(GCL;γ-谷氨酰半胱氨酸合成酶)的每个亚基,该异二聚体酶催化谷胱甘肽生物合成的限速步骤。通过Northern和Western印迹、酶活性和谷胱甘肽浓度评估,shRNA对催化亚基和调节亚基的独立靶向导致GCL破坏。在原代皮质神经元中沉默每个亚基会自发引发时间依赖性凋亡死亡,这一效应与谷氨酸或一氧化氮处理具有协同作用。此外,通过表达在shRNA靶cDNA序列内携带沉默突变的相应亚基全长cDNA以及用γ-谷氨酰半胱氨酸或谷胱甘肽乙酯孵育神经元,可以挽救GCL敲低引起的神经元凋亡。相比之下,从共培养的星形胶质细胞向神经元提供谷胱甘肽前体并不能预防GCL敲低引发的凋亡死亡。最后,过表达催化性(而非调节性)GCL亚基全长cDNA可增加酶活性和谷胱甘肽浓度,使神经元对谷氨酸或一氧化氮介导的凋亡更具抗性。因此,可以说神经元中GCL每个亚基的特异性和独立破坏会导致谷胱甘肽的原发性减少,足以促进神经退行性变。